卡尼金融储蓄 KRNY 深 沪
等待开盘 11-04 09:30:00 美东时间
6.41
+0.020
+0.31%
华盛通- 最 高6.42
- 今 开6.39
- 成交量 34.73万股
- 最 低 6.32
- 昨 收 6.39
- 总市值 4.15亿
- 52周最高 8.26
- 市盈率 静 15.42
- 换手率 0.54%
- 52周最低 5.225
- 委 比 -84.15%
- 总股本 6474.45万
- 历史最高 12.92
- 量 比 0.94
- 振 幅 1.56%
- 历史最低 2.3795
- 每 手 1
- 风险率 0.58%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Kearny Financial declares $0.11 dividend
Kearny Financial (NASDAQ:KRNY) declared $0.11/share quarterly dividend, in line with previous. Forward yield 6.55% Payable Nov. 19; for shareholders of record Nov. 5; ex-div Nov. 5. See KRNY Dividend ...
10-23 20:34
Kearny Financial Q1 Adj. EPS $0.15 Misses $0.16 Estimate, Sales $37.704M Beat $37.434M Estimate
Kearny Financial (NASDAQ:KRNY) reported quarterly earnings of $0.15 per share which missed the analyst consensus estimate of $0.16 by 6.25 percent. This is a 50 percent increase over earnings of $0.10 per share from the
10-23 20:31
Earnings Scheduled For October 23, 2025
Companies Reporting Before The Bell • Nokia (NYSE:NOK) is estimated to report q...
10-23 16:32
Kearny Financial Shifts to Offensive Growth Strategy
Kearny Financial ( ($KRNY) ) has provided an announcement. On October 21, 2025,...
10-21 20:47
Kura Oncology and Kyowa Kirin Launch Clinical Trial Evaluating Dual Inhibition of NPM1 and FLT3 Mutations in Patients with Newly Diagnosed Acute Myeloid Leukemia (AML)
Kura Oncology and Kyowa Kirin have initiated the first patient dosing in a cohort of the KOMET-007 clinical trial, evaluating ziftomenib, an investigational menin inhibitor, in combination with cytarabine and daunorubicin, along with quizartinib, for patients with newly diagnosed FLT3/NPM1 co-mutated acute myeloid leukemia (AML). Despite advances in FLT3 inhibitors, patients with FLT3/NPM1 co-mutations face high relapse rates and limited treatmen...
10-01 11:01
Kearny Financial And The Lab Consulting Partner To Enhance Operational Efficiency, Boost Workforce Productivity, And Elevate Client Experience
Kearny Financial Corp. (NASDAQ:KRNY) (the "Company"), a performance-driven financial institution committed to sustainable growth and innovation, today announced a strategic partnership with The Lab Consulting, a leading
10-01 02:40
Kearny Financial Corp. Partners with The Lab Consulting to Accelerate Operational Efficiency and Drive Shareholder Value
Kearny Financial Corp. announced a strategic partnership with The Lab Consulting to enhance operational efficiency, workforce productivity, and client experience through automation, AI, and process optimization. The initiative aims to deliver cost savings, scalability, and improved stakeholder returns. Key focus areas include RPA implementation, workflow integration, data analytics, and client experience redesign.
09-30 18:38
【美股IPO】“先买后付”数字支付巨头Klarna赴美IPO 引领9月上市潮
TradingKey - 据路透社报道，以提供“先买后付”（Buy Now, Pay Later，简称BNPL）服务闻名的瑞典金融科技巨头Klarna，计划9月重启赴美IPO（首次公开募股）。本周将确定发行价，价格区间为34-36美元每股，募资规模接近10亿美元。此次目标估值为130-140亿美元，远低于2021年设定的近500亿美元及今年早些时候超150亿美元的估值。
09-02 07:08
Kearny Financial Reports Strong Fiscal Year Results
Kearny Financial ( ($KRNY) ) has issued an announcement. On July 24, 2025, Kear...
07-24 20:57
Kearny Financial Q4 Adj. EPS $0.11 Misses $0.13 Estimate, Sales $40.83M Beat $35.89M Estimate
Kearny Financial (NASDAQ:KRNY) reported quarterly earnings of $0.11 per share which missed the analyst consensus estimate of $0.13 by 15.38 percent. This is a 22.22 percent increase over earnings of $0.09 per share from
07-24 20:41
